People: Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

32.13USD
21 Oct 2014
Price Change (% chg)

$0.21 (+0.66%)
Prev Close
$31.92
Open
$32.07
Day's High
$32.36
Day's Low
$31.34
Volume
514,681
Avg. Vol
1,086,264
52-wk High
$101.00
52-wk Low
$26.25

Search Stocks

Thomas, Paul 

Brief Biography

Mr. Paul G. Thomas serves as an Independent Director of Aegerion Pharmaceuticals, Inc., since August 1, 2011. Mr. Thomas is the founder of Roka Bioscience, Inc. (a privately held company principally engaged in the development and commercialization of molecular assays for biopharmaceutical processing, food safety and other industrial testing applications), and since September 2009 has served as its Chief Executive Officer. From October 1998 until August 2008, Mr. Thomas served as Chairman, Chief Executive Officer and President of LifeCell Corporation (a publicly traded company that developed and marketed innovative tissue repair products for use in reconstructive, orthopedic and urogynecologic surgical procedures). LifeCell was acquired in 2008 by Kinetic Concepts, Inc. Prior to joining LifeCell, Mr. Thomas was President and Chief Operating Officer of the Pharmaceutical Products Division of Ohmeda Inc. Mr. Thomas is also a member of the Board of Directors of AbioMed, Inc. (a leading provider of medical devices that provide circulatory support to acute heart failure patients across the continuum of care in heart recovery). During the past five years, Mr. Thomas has served as a director of Orthovita, Inc. Mr. Thomas holds a B.S. degree in chemistry from St. Michael’s College in Vermont, completed his post-graduate studies in chemistry at the University of Georgia Graduate School of Arts and Science, and received an M.B.A. degree with an emphasis in Marketing and Finance from Columbia University Graduate School of Business.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Scheer

--

Marc Beer

7,036,540

Mark Fitzpatrick

1,888,490

Carolina Alarco

--

Craig Fraser

1,979,770

Anne Cook

2,258,030
As Of 30 Dec 2013
Search Stocks